Calendar Gilead Sciences, Inc.

Equities

GILD

US3755581036

Real-time Estimate Cboe BZX 12:48:17 2024-04-24 EDT 5-day change 1st Jan Change
67 USD -0.04% Intraday chart for Gilead Sciences, Inc. +0.11% -17.29%

Chart calendar Gilead Sciences, Inc.

0275fb478183f80175a4fd6dc7f.uqnsdwAY1YnA4VG--vySnFDBqgCYUzQD9FFrwjZuOY8.jMqlA1ZS7PCvhSLKopTL_wCH5Tb8MFN0zCIzgG8vWNiJwdlDM0mSyPKFYQ~08c9243633df637b16bf82e1fcd68547

Upcoming events on Gilead Sciences, Inc.

2024-04-25 16:02 Q1 2024 Earnings Release
2024-04-25 16:30 Q1 2024 Earnings Call
2024-05-08 13:00 Annual General Meeting
2024-05-13 RBC Capital Markets Global Healthcare Conference
2024-07-29 Q2 2024 Earnings Release (Projected)
2024-10-23 Q3 2024 Earnings Release (Projected)
2025-02-10 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)

Past events on Gilead Sciences, Inc.

2024-03-14 10:00 Investor Meeting
2024-03-13 Ex-dividend day
2024-03-13 11:15 Barclays Global Healthcare Conference
2024-03-12 10:00 Leerink Partners Global Biopharma Conference
2024-03-05 12:50 TD Cowen Health Care Conference
2024-03-02 Conference on Retroviruses and Opportunistic Infections
2024-02-06 17:00 Q4 2023 Earnings Call
2024-02-06 16:02 Q4 2023 Earnings Release
2024-01-08 13:30 JPMorgan Healthcare Conference
2023-12-13 Ex-dividend day
2023-12-11 21:00 American Society of Hematology Meeting - Abstract Number : 4884
2023-12-11 21:00 American Society of Hematology Meeting - Abstract Number : 5101
2023-12-11 21:00 American Society of Hematology Meeting - Abstract Number : 4869
2023-12-11 21:00 American Society of Hematology Meeting - Abstract Number : 4865
2023-12-11 21:00 American Society of Hematology Meeting - Abstract Number : 5100
2023-12-11 21:00 American Society of Hematology Meeting - Abstract Number : 4864
2023-12-11 21:00 American Society of Hematology Meeting - Abstract Number : 5082
2023-12-11 21:00 American Society of Hematology Meeting - Abstract Number : 4424
2023-12-11 20:00 American Society of Hematology Meeting - Abstract Number : 1023
2023-12-11 20:00 American Society of Hematology Meeting - Abstract Number : 1029

Past dividends on Gilead Sciences, Inc.

2024-03-13 Quarterly 0.77 USD
2023-12-13 Quarterly 0.75 USD
2023-09-13 Quarterly 0.75 USD
2023-06-13 Quarterly 0.75 USD
2023-03-13 Quarterly 0.75 USD
2022-12-13 Quarterly 0.73 USD
2022-09-13 Quarterly 0.73 USD
2022-06-13 Quarterly 0.73 USD
2022-03-13 Quarterly 0.73 USD
2021-12-13 Quarterly 0.71 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
22 449
22 305
0.65%
24 689
24 482
0.84%
27 305
26 657
2.43%
27 281
26 518
2.88%
27 116
27 083
0.12%

27 505

EBITDA
Million USD
Released
Forecast
Spread
12 468
13 029
-4.3%
13 184
13 142
0.32%
14 598
15 539
-6.05%
14 283
13 783
3.63%
13 177
13 123
0.41%

9 281

EBIT
Million USD
Released
Forecast
Spread
11 064
11 571
-4.38%
11 704
11 599
0.9%
12 548
13 943
-10.01%
12 180
12 141
0.32%
10 484
10 687
-1.9%

7 113

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
5 160
5 333
-3.24%
1 669
1 636
2.01%
8 278
9 507
-12.92%
5 814
5 658
2.76%
6 859
7 323
-6.33%

4 238

Net income
Million USD
Released
Forecast
Spread
5 386
4 292
25.5%
123
137
-10.03%
6 225
7 205
-13.6%
4 592
4 383
4.77%
5 665
5 872
-3.52%

2 732

EPS
USD
Released
Forecast
Spread
4,22
3,43
23.14%
0,10
0,12
-16.23%
4,93
5,75
-14.19%
3,64
3,48
4.75%
4,50
4,69
-3.96%

2,23

Announcement Date04/02/2004/02/2101/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
7 244
6 615
9.51%
6 590
6 279
4.96%
6 260
5 873
6.6%
7 042
6 133
14.82%
7 389
6 630
11.45%
6 352
6 326
0.41%
6 599
6 454
2.24%
7 051
6 800
3.69%
7 115
7 104
0.16%

6 347


6 781


7 064


7 318


6 660

EBITDA
Million USD
Released
Forecast
Spread
2 042
3 449
-40.79%
4 049
3 438
17.79%
3 195
3 183
0.38%
3 811
3 049
24.99%
3 227
2 865
12.63%
2 883
3 407
-15.38%
3 258
3 343
-2.54%
3 908
3 636
7.49%
3 427
3 495
-1.94%

-889


3 322


3 692


3 562




EBIT
Million USD
Released
Forecast
Spread
1 507
2 905
-48.13%
3 524
3 060
15.15%
2 670
2 602
2.6%
3 286
2 529
29.91%
2 699
2 622
2.92%
2 243
2 658
-15.62%
2 277
2 776
-17.99%
3 224
3 060
5.37%
2 739
2 940
-6.84%

-1 705


2 800


3 099


2 956


2 803

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
759
1 966
-61.4%
-152
2 158
-107.05%
1 503
1 664
-9.68%
2 432
1 674
45.28%
2 031
1 840
10.37%
1 300
1 900
-31.59%
1 588
1 969
-19.35%
2 318
2 275
1.91%
1 653
2 090
-20.89%




1 867


2 337


2 311


2 122

Net income
Million USD
Released
Forecast
Spread
382
1 424
-73.17%
19,0
1 611
-98.82%
1 144
1 367
-16.32%
1 789
1 248
43.39%
1 640
1 438
14.02%
1 010
1 587
-36.37%
1 045
1 545
-32.38%
2 180
1 801
21.07%
1 429
1 599
-10.66%

-2 888


1 476


1 875


1 876


1 663

EPS
USD
Released
Forecast
Spread
0,30
1,14
-73.64%
0,02
1,34
-98.5%
0,91
1,11
-17.89%
1,42
1,01
40.93%
1,30
1,15
13%
0,80
1,23
-34.75%
0,83
1,20
-30.93%
1,73
1,43
20.88%
1,14
1,28
-11.05%

-1,99


1,25


1,50


1,38


1,32

Announcement Date01/02/2228/04/2202/08/2227/10/2202/02/2327/04/2303/08/2307/11/2306/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GILD Stock
  4. Calendar Gilead Sciences, Inc.